{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:01:55Z","timestamp":1791327715524,"version":"4.3.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,25]],"date-time":"2015-07-25T00:00:00Z","timestamp":1437782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2012_A103"],"award-info":[{"award-number":["2012_A103"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RE 752\/20-1"],"award-info":[{"award-number":["RE 752\/20-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/ 2007\u20132013"],"award-info":[{"award-number":["FP7\/ 2007\u20132013"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s40618-015-0353-0","type":"journal-article","created":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:13:13Z","timestamp":1437696793000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Genetics of Cushing\u2019s disease: an update"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2555-0602","authenticated-orcid":false,"given":"L. G.","family":"Perez-Rivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,25]]},"reference":[{"key":"353_CR1","first-page":"1","volume":"6736","author":"A Lacroix","year":"2015","unstructured":"Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015) Cushing\u2019s syndrome. Lancet 6736:1\u201315","journal-title":"Lancet"},{"key":"353_CR2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11102-015-0645-6","volume":"18","author":"ST Sharma","year":"2015","unstructured":"Sharma ST, Nieman LK, Feelders RA (2015) Comorbidities in Cushing\u2019s disease. Pituitary 18:188\u2013194","journal-title":"Pituitary"},{"key":"353_CR3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"Ezzat S, Asa SL, Couldwell WT et al (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613\u2013619","journal-title":"Cancer"},{"key":"353_CR4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/cen.12644","volume":"83","author":"LG Libuit","year":"2015","unstructured":"Libuit LG, Karageorgiadis AS, Sinaii N et al (2015) A gender-dependent analysis of Cushing\u2019s disease in childhood: pre-and postoperative follow-up. Clin Endocrinol 83:72\u201377","journal-title":"Clin Endocrinol"},{"key":"353_CR5","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1210\/jc.2003-031531","volume":"89","author":"HL Storr","year":"2004","unstructured":"Storr HL, Isidori AM, Monson JP et al (2004) Prepubertal Cushing\u2019s disease is more common in males, but there is no increase in severity at diagnosis. J Clin Endocrinol Metab 89:3818\u20133820","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1530\/EJE-10-1120","volume":"164","author":"HL Storr","year":"2011","unstructured":"Storr HL, Alexandraki KI, Martin L et al (2011) Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing\u2019s disease. Eur J Endocrinol 164:667\u2013674","journal-title":"Eur J Endocrinol"},{"key":"353_CR7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jc.2012-3604","volume":"98","author":"RR Lonser","year":"2013","unstructured":"Lonser RR, Wind JJ, Nieman LK et al (2013) Outcome of surgical treatment of 200 children with Cushing\u2019s disease. J Clin Endocrinol Metab 98:892\u2013901","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR8","first-page":"472","volume":"75","author":"C Gicquel","year":"1992","unstructured":"Gicquel C, Le Bouc Y, Luton JP et al (1992) Monoclonality of corticotroph macroadenomas in Cushing\u2019s disease. J Clin Endocrinol Metab 75:472\u2013475","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR9","first-page":"1303","volume":"75","author":"BM Biller","year":"1992","unstructured":"Biller BM, Alexander JM, Zervas NT et al (1992) Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing\u2019s disease. J Clin Endocrinol Metab 75:1303\u20131309","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1210\/jcem-73-6-1302","volume":"73","author":"HM Schulte","year":"1991","unstructured":"Schulte HM, Oldfield EH, Allolio B et al (1991) Clonal composition of pituitary adenomas in patients with Cushing\u2019s disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab 73:1302\u20131308","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1399-0004.2010.01406.x","volume":"78","author":"CA Stratakis","year":"2010","unstructured":"Stratakis CA, Tichomirowa MA, Boikos S et al (2010) The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet 78:457\u2013463","journal-title":"Clin Genet"},{"key":"353_CR12","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","volume":"92","author":"M Georgitsi","year":"2007","unstructured":"Georgitsi M, Raitila A, Karhu A et al (2007) Brief report: germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92:3321\u20133325","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.2012.04445.x","volume":"77","author":"M Korbonits","year":"2012","unstructured":"Korbonits M, Storr HL, Kumar AV (2012) Familial pituitary adenomas\u2014who should be tested for AIP mutations? Clin Endocrinol (Oxf) 77:351\u2013356","journal-title":"Clin Endocrinol (Oxf)"},{"key":"353_CR14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1210\/jc.2011-2291","volume":"97","author":"L Cazabat","year":"2012","unstructured":"Cazabat L, Bouligand J, Salenave S et al (2012) Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients. J Clin Endocrinol Metab 97:663\u2013670","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1530\/EJE-14-0426","volume":"171","author":"V Preda","year":"2014","unstructured":"Preda V, Korbonits M, Cudlip S et al (2014) Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort. Eur J Endocrinol 171:659\u2013666","journal-title":"Eur J Endocrinol"},{"key":"353_CR16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2362.1995.tb01537.x","volume":"25","author":"EA Williamson","year":"1995","unstructured":"Williamson EA, Ince PG, Harrison D et al (1995) G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur J Clin Invest 25:128\u2013131","journal-title":"Eur J Clin Invest"},{"key":"353_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/ERC-12-0118","volume":"19","author":"P Xekouki","year":"2012","unstructured":"Xekouki P, Stratakis CA (2012) Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and\/or Krebs cycle defects? Endocr Relat Cancer 19:33\u201340","journal-title":"Endocr Relat Cancer"},{"key":"353_CR18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/eje.1.01958","volume":"153","author":"E Menis De","year":"2005","unstructured":"De Menis E, Roncaroli F, Calvari V et al (2005) Corticotroph adenoma of the pituitary in a patient with X-linked adrenal hypoplasia congenita due to a novel mutation of the DAX-1 gene. Eur J Endocrinol 153:211\u2013215","journal-title":"Eur J Endocrinol"},{"key":"353_CR19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","volume":"128","author":"L Kock De","year":"2014","unstructured":"De Kock L, Sabbaghian N, Plourde F et al (2014) Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol 128:111\u2013122","journal-title":"Acta Neuropathol"},{"key":"353_CR20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11102-009-0194-y","volume":"14","author":"EM Pinto","year":"2011","unstructured":"Pinto EM, Siqueira SA, Cukier P et al (2011) Possible role of a radiation-induced p53 mutation in a Nelson\u2019s syndrome patient with a fatal outcome. Pituitary 14:400\u2013404","journal-title":"Pituitary"},{"key":"353_CR21","first-page":"296","volume":"108","author":"M Karl","year":"1996","unstructured":"Karl M, Lamberts SW, Koper JW et al (1996) Cushing\u2019s disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 108:296\u2013307","journal-title":"Proc Assoc Am Physicians"},{"key":"353_CR22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","volume":"45","author":"F Beuschlein","year":"2013","unstructured":"Beuschlein F, Boulkroun S, Osswald A et al (2013) Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 45:440\u2013444","journal-title":"Nat Genet"},{"key":"353_CR23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","volume":"370","author":"F Beuschlein","year":"2014","unstructured":"Beuschlein F, Fassnacht M, Assi\u00e9 G et al (2014) Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome. N Engl J Med 370:1019\u20131028","journal-title":"N Engl J Med"},{"key":"353_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2014","unstructured":"Reincke M, Sbiera S, Hayakawa A et al (2014) Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat Genet 47:31\u201338","journal-title":"Nat Genet"},{"key":"353_CR25","doi-asserted-by":"crossref","first-page":"E997","DOI":"10.1210\/jc.2015-1453","volume":"100","author":"LG P\u00e9rez-Rivas","year":"2015","unstructured":"P\u00e9rez-Rivas LG, Theodoropoulou M, Ferra\u00f9 F et al (2015) The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing\u2019s disease. J Clin Endocrinol Metab 100:E997\u2013E1004","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma ZY, Song ZJ, Chen JH et al (2015) Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res 25:306\u2013317","journal-title":"Cell Res"},{"key":"353_CR27","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1016\/j.yexcr.2007.07.028","volume":"313","author":"E Mizuno","year":"2007","unstructured":"Mizuno E, Kitamura N, Komada M (2007) 14-3-3-dependent inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phase. Exp Cell Res 313:3624\u20133634","journal-title":"Exp Cell Res"},{"key":"353_CR28","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1093\/emboj\/17.12.3241","volume":"17","author":"S Naviglio","year":"1998","unstructured":"Naviglio S (1998) UBPY: a growth-regulated human ubiquitin isopeptidase. EMBO J 17:3241\u20133250","journal-title":"EMBO J"},{"key":"353_CR29","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1128\/MCB.01566-06","volume":"27","author":"S Niendorf","year":"2007","unstructured":"Niendorf S, Oksche A, Kisser A et al (2007) Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo. Mol Cell Biol 27:5029\u20135039","journal-title":"Mol Cell Biol"},{"key":"353_CR30","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/MCB.01245-06","volume":"27","author":"Z Cao","year":"2007","unstructured":"Cao Z, Wu X, Yen L et al (2007) Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1. Mol Cell Biol 27:2180\u20132188","journal-title":"Mol Cell Biol"},{"key":"353_CR31","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1158\/1078-0432.CCR-12-3696","volume":"19","author":"S Byun","year":"2013","unstructured":"Byun S, Lee SYY, Lee J et al (2013) USP8 is a novel target for overcoming gefitinib resistance in lung cancer. Clin Cancer Res 19:3894\u20133904","journal-title":"Clin Cancer Res"},{"key":"353_CR32","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cellsig.2010.10.023","volume":"23","author":"IMJ Meijer","year":"2011","unstructured":"Meijer IMJ, van Leeuwen JEM (2011) ERBB2 is a target for USP8-mediated deubiquitination. Cell Signal 23:458\u2013467","journal-title":"Cell Signal"},{"key":"353_CR33","first-page":"a017459","volume":"5","author":"LK Goh","year":"2013","unstructured":"Goh LK, Sorkin A (2013) Endocytosis of receptor tyrosine kinases. Cold Spring Harb Perspect Biol 5:a017459","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"353_CR34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrm3048","volume":"12","author":"R Avraham","year":"2011","unstructured":"Avraham R, Yarden Y (2011) Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat Rev Mol Cell Biol 12:104\u2013117","journal-title":"Nat Rev Mol Cell Biol"},{"key":"353_CR35","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1091\/mbc.E05-06-0560","volume":"16","author":"E Mizuno","year":"2005","unstructured":"Mizuno E, Iura T, Mukai A et al (2005) Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes. Mol Biol Cell 16:5163\u20135174","journal-title":"Mol Biol Cell"},{"key":"353_CR36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02739916","volume":"7","author":"G Kontogeorgos","year":"1996","unstructured":"Kontogeorgos G, Stefaneanu L, Kovacs K, Cheng Z (1996) Localization of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFr) in human pituitary adenomas and nontumorous pituitaries: an immunocytochemical study. Endocr Pathol 7:63\u201370","journal-title":"Endocr Pathol"},{"key":"353_CR37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1677\/joe.1.05616","volume":"183","author":"M Theodoropoulou","year":"2004","unstructured":"Theodoropoulou M, Arzberger T, Gruebler Y et al (2004) Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. J Endocrinol 183:385\u2013394","journal-title":"J Endocrinol"},{"key":"353_CR38","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/modpathol.3800118","volume":"17","author":"O Onguru","year":"2004","unstructured":"Onguru O, Scheithauer BW, Kovacs K et al (2004) Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas. Mod Pathol 17:772\u2013780","journal-title":"Mod Pathol"},{"key":"353_CR39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000054532","volume":"71","author":"J Honda","year":"2000","unstructured":"Honda J, Oomizu S, Kiuchi Y et al (2000) Identification of epidermal growth factor mRNA-expressing cells in the mouse anterior pituitary. Neuroendocrinology 71:155\u2013162","journal-title":"Neuroendocrinology"},{"key":"353_CR40","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","volume":"121","author":"H Fukuoka","year":"2011","unstructured":"Fukuoka H, Cooper O, Ben-Shlomo A et al (2011) EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas. J Clin Invest 121:4712\u20134721","journal-title":"J Clin Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0353-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0353-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0353-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:03:42Z","timestamp":1559502222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0353-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,25]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0353-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726005404.793530693","asserted-by":"object"}]},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,25]]}}}